- Home
- CCEL vs PXS Comparison
CCEL vs PXS Comparison
Compare CCEL & PXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- PXS
- Stock Information
- Founded
- CCEL 1989
- PXS 2015
- Country
- CCEL United States
- PXS Greece
- Employees
- CCEL N/A
- PXS N/A
- Industry
- CCEL Managed Health Care
- PXS Marine Transportation
- Sector
- CCEL Health Care
- PXS Consumer Discretionary
- Exchange
- CCEL Nasdaq
- PXS Nasdaq
- Market Cap
- CCEL 39.9M
- PXS 30.2M
- IPO Year
- CCEL 1997
- PXS N/A
- Fundamental
- Price
- CCEL $4.83
- PXS $2.98
- Analyst Decision
- CCEL Strong Buy
- PXS Strong Buy
- Analyst Count
- CCEL 1
- PXS 1
- Target Price
- CCEL $8.50
- PXS $10.00
- AVG Volume (30 Days)
- CCEL 13.1K
- PXS 53.5K
- Earning Date
- CCEL 07-22-2025
- PXS 08-11-2025
- Dividend Yield
- CCEL 20.62%
- PXS N/A
- EPS Growth
- CCEL N/A
- PXS N/A
- EPS
- CCEL 0.01
- PXS 0.63
- Revenue
- CCEL $32,102,750.00
- PXS $49,342,000.00
- Revenue This Year
- CCEL $2.49
- PXS N/A
- Revenue Next Year
- CCEL $0.95
- PXS $31.36
- P/E Ratio
- CCEL $303.41
- PXS $4.65
- Revenue Growth
- CCEL 2.33
- PXS 8.07
- 52 Week Low
- CCEL $4.75
- PXS $2.53
- 52 Week High
- CCEL $9.43
- PXS $5.53
- Technical
- Relative Strength Index (RSI)
- CCEL 40.85
- PXS 53.18
- Support Level
- CCEL $4.80
- PXS $2.76
- Resistance Level
- CCEL $6.35
- PXS $2.93
- Average True Range (ATR)
- CCEL 0.26
- PXS 0.11
- MACD
- CCEL -0.03
- PXS 0.01
- Stochastic Oscillator
- CCEL 2.08
- PXS 47.13
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About PXS Pyxis Tankers Inc.
Pyxis Tankers Inc is an international maritime transportation company focused on mid-sized eco-vessels for the product tanker and dry-bulk sectors. It owns a fleet that comprises double-hull product tankers employed under a mix of short- and medium-term time charters and spot charters. The fleet owned by the company includes Konkar Ormi, Pyxis Lamda, Konkar Venture, Pyxis Karteria, and others. Each of the vessels in the fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, fuel oil, and other liquid bulk items, such as vegetable oils and organic chemicals. The company operates under two reportable segments, Tanker Vessels, which derive maximum revenue, and Dry-bulk Vessels.